This inventor holds 1 USPTO granted patent. Top assignees: Xiamen Innovax Biotech Co., Ltd., Xiamen University. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: The Innovative Contributions of Cai Zhang
Introduction
Cai Zhang is a notable inventor based in Fujian, China. He has made significant contributions to the field of vaccine adjuvants, particularly through his innovative work on zinc zoledronate micro-nanoparticles. His research focuses on enhancing vaccine efficacy, which is crucial in the fight against various diseases.
Latest Patents
Cai Zhang holds a patent for the "Preparation of zinc zoledronate micro-nanoparticle adjuvant and use thereof as vaccine adjuvant." This patent describes a zinc zoledronate micro-nanoparticle adjuvant that contains zinc and zoledronic acid, and may also include phosphate and aluminum. The preparation method involves mixed precipitation on a soluble salt solution containing zinc ions, zoledronic acid, and sodium hydroxide. This innovative adjuvant can be utilized in the preparation of vaccines, enhancing their effectiveness.
Career Highlights
Throughout his career, Cai Zhang has worked with prominent organizations such as Xiamen Innovax Biotech Co., Ltd. and Xiamen University. His experience in these institutions has allowed him to develop and refine his research in vaccine adjuvants, contributing to advancements in immunology.
Collaborations
Cai Zhang has collaborated with various professionals in his field, including his coworker Xiaofen Huang. These collaborations have fostered a productive environment for innovation and research.
Conclusion
Cai Zhang's work in developing zinc zoledronate micro-nanoparticle adjuvants represents a significant advancement in vaccine technology. His contributions are vital for improving vaccine efficacy and public health.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile